Abstract

MUCORMYCOSIS: A BRIEF REVIEW

Dr. Pankaj Chaudhari*, Priyanka Patil, Radhika Rajput, Divya Rajput and Pallavi Shirole

ABSTRACT

Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. The prevalence of mucormycosis in India is about 80 times the prevalence in developed countries, being approximately 0.14 cases per 1000 population. The aim of this article is to present an update on the epidemiology and the available diagnostic methods for this potentially lethal disease. Overall increased mortality rate is reported, even though the aggressive treatment is given. The review related to overview and Etiopathogenesis of Mucormycosis, fatality of rhinocerebral Mucormycosis, recent advances in diagnostic and treatment methods. Mucorales possess a certain range of resistance to common antifungal agents. Although, Amphotericin B, Posaconazole, and isavuconazole are possible first-line treatments. COVID-19 infected patients with black fungus are receiving first-line antifungal drugs to mitigate the infections. Much more research needed for the discovery of new drug therapy in the coming future.

Keywords: Mucormycosis, Etiopathogenesis, angioinvasive.